Futibatinib in Patients With Specific FGFR Aberrations

Clinical trial NCT04189445 · TERMINATED

Trial details

NCT number: NCT04189445
Sponsor: Taiho Oncology, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumor Advanced or Metastatic Gastric or Gastroesophageal Cancer Myeloid or Lymphoid Neoplasms (MLN)

Start date: 2020-08-05
Primary completion: 2024-11-11
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.